Question

In: Finance

A project with an up-front cost at t = 0 of $1500 is being considered by...

A project with an up-front cost at t = 0 of $1500 is being considered by Nationwide Pharmaceutical Corporation (NPC). (All dollars in this problem are in thousands.) The project's subsequent cash flows are critically dependent on whether a competitor's product is approved by the Food and Drug Administration. If the FDA rejects the competitive product, NPC's product will have high sales and cash flows, but if the competitive product is approved, that will negatively impact NPC. There is a 75% chance that the competitive product will be rejected, in which case NPC's expected cash flows will be $500 at the end of each of the next seven years (t = 1 to 7). There is a 25% chance that the competitor's product will be approved, in which case the expected cash flows will be only $25 at the end of each of the next seven years (t = 1 to 7). NPC will know for sure one year from today whether the competitor's product has been approved.

NPC will proceed with the investment today to take advantage of the untapped market potential and at the end of the projects life, after finding out about the FDA,s decision about the demand for competitors product, they will decide wether or not to renew the patent and return the project. The project return's up-front cost (at t=7) will remain at $1,500, and the subsequent cash flows will remain unchanged and will be recieved for seven additional years (t=8...14). They will only return the project if the return of the project adds value.  

Assuming that all cash flows are discounted at 10%, what is the NPV of the project with and without growth option?

Solutions

Expert Solution

  1. NPV without Growth Option

Good Scenario (75%)

Worse Scenario (25%)

Year

PV Factors

Cash Flows

PV

Cash Flows

PV

0

1

-1500

-1500

-1500

-1500

1

0.9090909

500

454.55

25

22.73

2

0.8264463

500

413.22

25

20.66

3

0.7513148

500

375.66

25

18.78

4

0.6830135

500

341.51

25

17.08

5

0.6209213

500

310.46

25

15.52

6

0.5644739

500

282.24

25

14.11

7

0.5131581

500

256.58

25

12.83

NPV

934.21

-1378.29

Expected NPV = NPV * Probability = ($934.21*75% + (-1378 * 25%)) = $356.157

  1. NPV with Growth Option

Good Scenario (75%)

Worse Scenario (25%)

Year

PV Factors

Cash Flows

PV

Cash Flows

PV

0

1

-1500

-1500

-1500

-1500

1

0.90909

500

454.55

25

22.73

2

0.82645

500

413.22

25

20.66

3

0.75131

500

375.66

25

18.78

4

0.68301

500

341.51

25

17.08

5

0.62092

500

310.46

25

15.52

6

0.56447

500

282.24

25

14.11

7

0.51316

(500 + (-1500)

-513.16

(25 + (-1500)

-756.91

8

0.46651

500

233.25

25

11.66

9

0.42410

500

212.05

25

10.60

10

0.38554

500

192.77

25

9.64

11

0.35049

500

175.25

25

8.76

12

0.31863

500

159.32

25

7.97

13

0.28966

500

144.83

25

7.24

14

0.26333

500

131.67

25

6.58

NPV

1413.61

-2085.57

Expected NPV = NPV * Probability = ($1413.61*75% + (-2085.57* 25%)) = $538.95


Related Solutions

A project with an up-front cost at t = 0 of $1500 is being considered by...
A project with an up-front cost at t = 0 of $1500 is being considered by Nationwide Pharmaceutical Corporation (NPC). (All dollars in this problem are in thousands.) The project's subsequent cash flows are critically dependent on whether a competitor's product is approved by the Food and Drug Administration. If the FDA rejects the competitive product, NPC's product will have high sales and cash flows, but if the competitive product is approved, that will negatively impact NPC. There is a...
1. A project with an up-front cost at t=0 of $1500 is being considered by Nationwide...
1. A project with an up-front cost at t=0 of $1500 is being considered by Nationwide Pharmaceutical Corporation (NPC). (All dollars in this problem are in thousands.) The project’s subsequent cash flows are critically dependent on whether a competitor’s product is approved by the Food and Drug Administration. If the FDA rejects the competitive product, NPC’s product will have high sales and cash flows, but if the competitive product is approved, that will negatively impact NPC. There is a 75%...
A project with an up-front cost at t=0 of $1500 is being considered by Nationwide Pharmaceutical...
A project with an up-front cost at t=0 of $1500 is being considered by Nationwide Pharmaceutical Corporation (NPC). (All dollars in this problem are in thousands.) The project’s subsequent cash flows are critically dependent on whether a competitor’s product that is now under development is approved by the Food and Drug Administration. If the FDA rejects the competitive product upon the completion of its development, NPC’s product will have high sales and cash flows, but if the competitive product is...
3. A project with an up-front cost at t=0 of $1500 is being considered by Nationwide...
3. A project with an up-front cost at t=0 of $1500 is being considered by Nationwide PharmaceuticalCorporation (NPC). (All dollars in this problem are in thousands.) The project’s subsequent cash flows arecritically dependent on whether a competitor’s product that is now under development is approved by the Food and Drug Administration. If the FDA rejects the competitive product upon the completion of its development, NPC’s product will have high sales and cash flows, but if the competitive product is approved,...
2. A project with an up-front cost at t=0 of $1500 is being considered by Nationwide...
2. A project with an up-front cost at t=0 of $1500 is being considered by Nationwide Pharmaceutical Corporation (NPC). (All dollars in this problem are in thousands.) The project’s subsequent cash flows are critically dependent on whether a competitor’s product that is now under development is approved by the Food and Drug Administration. If the FDA rejects the competitive product upon the completion of its development, NPC’s product will have high sales and cash flows, but if the competitive product...
1. A project with an up-front cost at t=0 of $1500 is being considered by Nationwide...
1. A project with an up-front cost at t=0 of $1500 is being considered by Nationwide Pharmaceutical Corporation (NPC). (All dollars in this problem are in thousands.) The project’s subsequent cash flows are critically dependent on whether a competitor’s product is approved by the Food and Drug Administration. If the FDA rejects the competitive product, NPC’s product will have high sales and cash flows, but if the competitive product is approved, that will negatively impact NPC. There is a 75%...
Firm C is considering a project with an up-front cost at t = 0 of $1500....
Firm C is considering a project with an up-front cost at t = 0 of $1500. (All dollars in this problem are in thousands.) The project’s subsequent cash flows are critically dependent on whether a competitor’s product is approved by the Food and Drug Administration (FDA). If the FDA rejects the competitive product, C’s product will have high sales and cash flows, but if the competitive product is approved, that will negatively impact company C. There is a 75% chance...
A project has an initial, up-front cost of $10,000, at t = 0. The project is...
A project has an initial, up-front cost of $10,000, at t = 0. The project is expected to produce cash flows of $2,200 for the next three years. The project’s cash flows depend critically upon customer acceptance of the product. There is a 60% probability that the product will be wildly successful and produce CFs of $5,000, and a 40% chance it will produce annual CFs of -$2,000. At a 10% WACC, what is this project’s NPV with abandonment option?...
The Z-90 project being considered by Steppingstone Inc. (SI) has an up-front cost of $250,000. The...
The Z-90 project being considered by Steppingstone Inc. (SI) has an up-front cost of $250,000. The project's subsequent cash flows are critically dependent on whether another one of its products, Z-45, becomes an industry standard. There is a 60% chance that the Z-45 will become the industry standard, in whihc case the Z-90's expected cash flows will be $110,000 at the end of each of the next 5 years. There is a 40% chance that the Z-45 will not become...
A company is considering a project that has an up-front cost paid today at t =...
A company is considering a project that has an up-front cost paid today at t = 0. The project will generate positive cash flows of $50,175 a year at the end of each for the next 5 years. The project’s NPV is $87,983 and the company’s return on the project is 8.3 percent. What is the project’s payback?
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT